Trump touts lower drug costs and anti-fraud measures in lengthy State of the Union
President Trump used the State of the Union to highlight lower drug prices and anti-fraud measures and urged Congress to codify a Most Favored Nation (MFN) drug-pricing policy. The speech also emphasized TrumpRx price transparency, proposed shifts in Medicare/Medicaid policy, and changes to vaccine and gender-affirming care oversight under HHS leadership.
Why it mattersMFN drug-pricing push and TrumpRx could reduce pharma revenues, forcing repriced valuations and licensing strategies.
Entities Mentioned
PhRMACenters for Medicare and Medicaid ServicesDepartment of JusticeDepartment of Health and Human ServicesCenters for Disease Control and PreventionAdvisory Committee on Immunization PracticesWhite House
People Mentioned
Mehmet OzStephen J. UblJohn ThuneMike JohnsonRobert F. Kennedy Jr